Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel Specifically, A.
Inspection Record
Emergent Manufacturing Operations Baltimore LLC — FDA 483 Findings
Inspectors Marcellinus D DordunooThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
Separate or defined areas to prevent contamination or mix-ups are deficient regarding operations related to the holding of rejected components before disposition.
Employees are not given training in the particular operations they perform as part of their function and current good manufacturing practices.
Established specifications, test procedures and laboratory control mechanisms are not followed and documented at the time of performance.
About this record
Extracted automatically from the document US FDA published on 2021-04-23. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
